Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | METAP1 | P53582 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MITF | O75030 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 8/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23914284 | 0.79 | METAP1 (0.37) | METAP1MEN1MITFPOLBKMT2A | |
| SCHEMBL23914336 | 0.77 | METAP1 (0.43) | METAP1CHRNA7LMNA | |
| SCHEMBL16575259 | 0.75 | POLB (0.34) | METAP1MEN1MITFPOLBKMT2A | |
| SCHEMBL16575250 | 0.74 | METAP1 (0.34) | METAP1CHRNA7 | |
| SCHEMBL16575251 | 0.74 | MEN1 (0.35) | METAP1MEN1MITFPOLBKMT2A | |
| SCHEMBL16575248 | 0.73 | HSD11B1 (0.36) | MEN1MITFPOLBKMT2A | |
| SCHEMBL18588668 | 0.72 | HSD11B1 (0.40) | MEN1MITFPOLBKMT2ACHRNA7 | |
| SCHEMBL3122943 | 0.72 | L3MBTL1 (0.49) | L3MBTL1KDM4ENPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL16575256 | 0.71 | CHRNA7 (0.33) | METAP1MEN1MITFPOLBKMT2A | |
| SCHEMBL12768178 | 0.68 | SMN1; SMN2 (0.48) | L3MBTL1KDM4ENPC1SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | L3MBTL1 361/4885KDM4E 2541/4885NPC1 4363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.